Times Square Capital Management, LLC Charles River Laboratories International, Inc. Transaction History

Times Square Capital Management, LLC

$6.49 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$206.39 - $268.73 $1.2 Million - $1.56 Million	-5,795 Reduced 4.29%	129,208 $26.7 Million
Q1 2024 May 07, 2024	BUY	$203.52 - $273.43 $21 Million - $28.2 Million	103,168 Added 324.07%	135,003 $36.6 Million
Q4 2023 Feb 07, 2024	BUY	$164.52 - $238.84 $5.24 Million - $7.6 Million	31,835 New	31,835 $7.53 Million
Q4 2022 Feb 10, 2023	SELL	$197.11 - $250.07 $1.4 Million - $1.78 Million	-7,104 Reduced 19.2%	29,900 $6.52 Million
Q3 2022 Nov 09, 2022	SELL	$182.44 - $250.54 $36.7 Million - $50.4 Million	-201,200 Reduced 84.47%	37,004 $7.28 Million
Q2 2022 Aug 05, 2022	SELL	$204.13 - $302.4 $17.1 Million - $25.3 Million	-83,750 Reduced 26.01%	238,204 $51 Million
Q1 2022 May 06, 2022	SELL	$255.51 - $362.11 $14.6 Million - $20.7 Million	-57,250 Reduced 15.1%	321,954 $91.4 Million
Q4 2021 Feb 04, 2022	BUY	$351.38 - $448.68 $1.09 Million - $1.39 Million	3,104 Added 0.83%	379,204 $143 Million
Q3 2021 Nov 08, 2021	SELL	$372.64 - $458.3 $46.4 Million - $57.1 Million	-124,600 Reduced 24.89%	376,100 $155 Million
Q2 2021 Aug 09, 2021	SELL	$294.17 - $371.65 $27.4 Million - $34.6 Million	-93,050 Reduced 15.67%	500,700 $185 Million
Q1 2021 May 12, 2021	SELL	$249.67 - $299.48 $53.8 Million - $64.5 Million	-215,300 Reduced 26.61%	593,750 $172 Million
Q4 2020 Feb 12, 2021	BUY	$222.0 - $252.62 $43.4 Million - $49.4 Million	195,375 Added 31.84%	809,050 $202 Million
Q3 2020 Nov 06, 2020	SELL	$175.56 - $226.45 $5.29 Million - $6.82 Million	-30,135 Reduced 4.68%	613,675 $139 Million
Q2 2020 Aug 07, 2020	SELL	$118.84 - $189.72 $10.7 Million - $17.1 Million	-90,040 Reduced 12.27%	643,810 $112 Million
Q1 2020 May 08, 2020	SELL	$98.9 - $178.34 $5.93 Million - $10.7 Million	-59,925 Reduced 7.55%	733,850 $92.6 Million
Q4 2019 Feb 05, 2020	SELL	$126.05 - $152.76 $27 Million - $32.7 Million	-213,975 Reduced 21.23%	793,775 $121 Million
Q3 2019 Nov 05, 2019	BUY	$125.07 - $143.67 $12.5 Million - $14.4 Million	99,900 Added 11.0%	1,007,750 $133 Million
Q2 2019 Aug 02, 2019	BUY	$123.4 - $148.55 $5.46 Million - $6.58 Million	44,275 Added 5.13%	907,850 $129 Million
Q1 2019 May 10, 2019	SELL	$104.82 - $146.73 $17.1 Million - $24 Million	-163,475 Reduced 15.92%	863,575 $125 Million
Q4 2018 Feb 14, 2019	SELL	$105.09 - $137.23 $14.2 Million - $18.5 Million	-135,125 Reduced 11.63%	1,027,050 $116 Million
Q3 2018 Nov 14, 2018	BUY	$112.11 - $134.54 $17.1 Million - $20.5 Million	152,505 Added 15.1%	1,162,175 $0
Q2 2018 Aug 14, 2018	BUY	$102.37 - $117.25 $15.3 Million - $17.5 Million	149,550 Added 17.39%	1,009,670 $113 Million
Q1 2018 May 15, 2018	SELL	$98.19 - $115.2 $5.45 Million - $6.39 Million	-55,480 Reduced 6.06%	860,120 $91.8 Million
Q4 2017 Feb 14, 2018	BUY	$100.43 - $118.09 $59.2 Million - $69.7 Million	589,900 Added 181.12%	915,600 $100 Million
Q3 2017 Nov 09, 2017	BUY	$96.72 - $109.26 $31.5 Million - $35.6 Million	325,700	325,700 $35.2 Million

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1.16 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$966 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.74M
Shares

$710 Million
0.13% of portfolio
State Street Corp Boston, MA

2.13M
Shares

$404 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.94M
Shares

$368 Million
0.87% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.65B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Times Square Capital Management, LLC with notifications on news.

Account